Stocks and InvestingStocks and Investing
Thu, April 8, 2021
Wed, April 7, 2021
Tue, April 6, 2021
Mon, April 5, 2021
Sun, April 4, 2021
Thu, April 1, 2021

Joseph Pantginis Maintained (ATNM) at Strong Buy with Decreased Target to $57 on, Apr 1st, 2021


Published on 2024-10-27 16:06:21 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Decreased Target from $65 to $57 on, Apr 1st, 2021.

Joseph, nor any peers, have made any analyst calls on ATNM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30